Evidence map›Paper›PMID 18675921›Full record

ArticleCell biology international2008

IGF2-driven PI3 kinase and TGFbeta signaling pathways in chondrogenesis.

Kazunori Hamamura, Ping Zhang, Hiroki Yokota

Open access · greenAbstract read
In one paragraph

Article in Cell biology international, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Advanced biomedical research · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Role of SOX9 in IGF-II-Mediated Pulmonary Fibrosis.International journal of molecular sciences · 2023
    Article
  8. Cells · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Kazunori HamamuraDepartment of Biomedical Engineering, Indiana University - Purdue University Indianapolis, Indianapolis, IN 46202, USA.
Ping Zhang
Hiroki Yokota
Indiana University – Purdue University Indianapolis · USIndiana University School of MedicineUniversity of Indianapolis · US

Funding

Mechanical response of osteoblasts in 3D matrixR01AR050008 · NIAMS · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI YOKOTA, HIROKI · 2004 to 2007
$829k
NIAMS NIH HHS R01 AR050008NIAMS NIH HHS R01-AR50008
6 · The paper itself

Abstract

Insulin-like growth factor-2 (IGF2) is essential for fetal development as well as maintenance of adult organs such as brain and liver. Although genetic polymorphisms of IGF2 are linked to cytoskeletal variations little is known about the mechanisms of IGF2 action in proliferation and differentiation of chondrocytes for skeletal growth. A genome-wide mRNA expression analysis using C28/I2 chondrocyte cells studied potential signaling pathways underlying the responses to IGF2. Microarray data predicted involvement of the phosphatidylinositol 3-kinase (PI3K) and transforming growth factor beta (TGFbeta) signaling pathways. Protein analyses revealed IGF2 administration activated phosphorylation of Akt and GSK3beta in the PI3K pathway. LY294002 (selective inhibitor of PI3K) blocked Akt phosphorylation and abolished IGF2-driven elevation of the mRNA levels of the proteoglycans, Aggrecan and Versican. LY294002 did not suppress upregulation of TGFbeta mRNA induced by IGF2, so IGF2 activates PI3K and TGFbeta pathways. IGF2-driven transcriptional activation of proteoglycan genes such as Aggrecan and Versican is mediated by the PI3K pathway.

Indexed as

AggrecansCells, CulturedChondrocytesChondrogenesisChromonesEnzyme InhibitorsGene Expression ProfilingGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaHumansInsulin-Like Growth Factor IIMicroarray AnalysisMorpholinesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal Transduction2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-oneACAN protein, humanAggrecansChromonesEnzyme InhibitorsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGSK3B protein, humanInsulin-Like Growth Factor IIMorpholinesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktTransforming Growth Factor betaVCAN protein, humanVersicans

Identifiers

PMID18675921
PMCPMC2586935
OpenAlexW2154041263

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.